The question is, will Mr. Market connect the dots with all the other Ridaforolimus trials in the pipeline with Merck and Ariad and continue the momentum, or do we get a temporary pull back? I expect there is no looking back..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.